Chlorpromazine hydrochloride
Chlorpromazine Hydrochloride is a prescription injectable medication containing 25 mg/mL of the active ingredient, used for intramuscular administration. Manufactured by Zydus Pharmaceuticals USA Inc., it belongs to the phenothiazine class and is approved under ANDA217275 for treating certain psychiatric conditions. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Chlorpromazine Hydrochloride is a prescription injectable medication containing 25 mg/mL of the active ingredient, used for intramuscular administration. Manufactured by Zydus Pharmaceuticals USA Inc., it belongs to the phenothiazine class and is approved under ANDA217275 for treating certain psychiatric conditions. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Chlorpromazine hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Chlorpromazine hydrochloride — ANDA 083329 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083329"
}
]
|
| identifier | ANDA083329 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"fda",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Chlorpromazine hydrochloride |
